Vinnova grants one-carbon therapeutics money

mars 29, 2022

One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency Vinnova under the Medtech4Health and SweLife programs for further development of the MTHFD2 program.

One-carbon Therapeutics to Present Trial-in-Progress Poster on ODIN Phase 1/2 Study ofTH9619 at the 2026 ASCO Annual Meeting

Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage

One-carbon Therapeutics Strengthens Board of Directors with Appointment of Stefan Larsson and Raj Shah

Solna, Sweden, May 21, 2026. One-carbon Therapeutics AB, a clinical-stage